Sarah Catharine Punshon, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 135 Reichart Ave, Wintersville, OH 43953 Phone: 740-264-1155 |
Mrs. Justine Lynn Krivoniak, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 135 Reichart Ave, Wintersville, OH 43953 Phone: 740-266-6940 Fax: 740-266-6942 |
News Archive
Tens of millions of patients around the world suffer from persistent and potentially life-threatening wounds. These chronic wounds, which are also a leading cause of amputation, have treatments, but the cost of existing wound dressings can prevent them from reaching people in need.
With national statistics indicating that one of every three hospitalized patients requires insulin therapy during their stay, administering the right dose at the right time in accordance with best practices is integral to safe, effective care and speedy recovery
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it presented updated safety and clinical activity data from the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT⢠(CA4P) in patients with non-small cell lung cancer (NSCLC), at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO).
Portable devices that use a laser beam to probe bones, teeth, and other parts of the body for early signs of diseases like osteoporosis and tooth decay may seem like something out of science fiction. But those devices are moving closer to reality, according to an article in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.
› Verified 9 days ago